Illumina, Facing Dip in Array Demand, Posts 12-Percent Rise in Q4 Sales

Product revenue for the quarter rose 10 percent on "significant growth" in its sequencing products. Instruments sales rose 19 percent largely on the back of "strong growth in sequencing instrumentation, which was partially offset by lower sales of array instruments during the quarter."

Affy Says Q4 Revenues Up 13 Percent on 'Solid Increase' in Genotyping Sales

Driving the growth was increased adoption of its next-generation genotyping platform for genome-wide association studies, as well as "strong" sales of products for copy number studies, custom genotyping, and biomarker discovery and validation.

Roche NimbleGen Array Sales Rise 44 Percent in '09

The growth was fueled by "continued strong performance" of Roche NimbleGen's sequence capture arrays as well as the introduction of its high-throughput MS 200 microarray scanner.

Duke University Medical Center Researchers Warn 'GWAS Will Hit a Wall'

While they acknowledge that genome-wide association studies have been effective in finding common variants associated with human disease, the researchers caution in a new PLoS Biology paper that rare, undetected variants may underlie those associations.

CombiMatrix to Spend $25M Insurance Settlement on 'All Aspects of Business'

The settlement ends a legal battle that began more than two years ago when CombiMatrix filed a suit claiming that the insurance firm had refused to defend and indemnify CombiMatrix under its director and officer’s insurance policy.

Elitech Sells Nanogen Microarray Assets to Gamida for Life Group

Yacob Ofer, president of Gamida's diagnostics business, said that the acquisition of NanoChip array assets from Elitech gives the firm the ability to continue to service the "large and growing" number of customers in Israel.

France's Institut Pasteur Develops Resequencing Array for Pathogen Identification

The investigators validated the chip in a recent study by evaluating its ability to detect re-assorted strains of swine-origin H1N1 influenza A virus.

In Print

Microarray Papers of Note Published January 2010

IP Roundup

Osmetech, Agency for Science, Technology and Research of Singapore, Ciencia, Rubicon Genomics, Samsung Electronics

New Product Watch

Oxford Gene Technology

People in the News

Mark McGowan, Mike Hoerres, Wolfgang Holzgreve

Illumina to Submit Cytogenetics Package to FDA, Commits to Using Arrays in Dx

The decision marks a shift in strategy for Illumina, which had previously positioned its digital microbead-based BeadXpress reader as its diagnostics platform of choice. Now it will seek FDA clearance for clinical use of its arrays, too.

Fluidigm Pens Services Deal with IntegraGen in Europe

For South San Francisco, Calif.-based Fluidigm, the deal increases its presence in a European market where sales, though on the rise, remain "spotty" due to varying economic conditions from country to country.